Guided Therapeutics, Inc. (GTHP)
USD 0.1
(55.28%)
USD 0.1
(55.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.46 Million USD | 3034.0% |
| 2022 | -50 Thousand USD | -102.22% |
| 2021 | 2.25 Million USD | -46.58% |
| 2020 | 4.22 Million USD | -17.52% |
| 2019 | 5.12 Million USD | 0.45% |
| 2018 | 5.09 Million USD | 9.83% |
| 2017 | 4.64 Million USD | 15.45% |
| 2016 | 4.02 Million USD | 161.72% |
| 2015 | 1.53 Million USD | -38.36% |
| 2014 | 2.49 Million USD | 780.87% |
| 2013 | -366 Thousand USD | 32.47% |
| 2012 | -542 Thousand USD | 69.53% |
| 2011 | -1.77 Million USD | 32.18% |
| 2010 | -2.62 Million USD | -130.96% |
| 2009 | 8.47 Million USD | 103.09% |
| 2008 | 4.17 Million USD | 54.31% |
| 2007 | 2.7 Million USD | -24.16% |
| 2006 | 3.56 Million USD | 5141.18% |
| 2005 | 68 Thousand USD | -48.87% |
| 2004 | 133 Thousand USD | -78.82% |
| 2003 | 628 Thousand USD | 235.05% |
| 2002 | -465 Thousand USD | 95.08% |
| 2001 | -9.45 Million USD | -162.07% |
| 2000 | -3.6 Million USD | -71.86% |
| 1999 | -2.1 Million USD | 58.0% |
| 1998 | -5 Million USD | 58.68% |
| 1997 | -12.1 Million USD | -175.0% |
| 1996 | -4.4 Million USD | -1289.19% |
| 1995 | 370 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.57 Million USD | 7.63% |
| 2024 Q2 | 1.86 Million USD | 18.18% |
| 2023 FY | 1.46 Million USD | 3034.0% |
| 2023 Q1 | 274 Thousand USD | 648.0% |
| 2023 Q2 | 732 Thousand USD | 167.15% |
| 2023 Q3 | 1.35 Million USD | 84.97% |
| 2023 Q4 | 1.46 Million USD | 8.35% |
| 2022 Q1 | 2.11 Million USD | -6.25% |
| 2022 FY | -50 Thousand USD | -102.22% |
| 2022 Q2 | 2.6 Million USD | 22.98% |
| 2022 Q3 | -30 Thousand USD | -101.15% |
| 2022 Q4 | -50 Thousand USD | -66.67% |
| 2021 Q2 | 2.11 Million USD | 63.98% |
| 2021 Q1 | 1.29 Million USD | -69.43% |
| 2021 Q3 | 2.27 Million USD | 7.65% |
| 2021 FY | 2.25 Million USD | -46.58% |
| 2021 Q4 | 2.25 Million USD | -1.01% |
| 2020 FY | 4.22 Million USD | -17.52% |
| 2020 Q1 | 3.89 Million USD | -23.91% |
| 2020 Q2 | 3.13 Million USD | -19.46% |
| 2020 Q3 | 3.31 Million USD | 5.64% |
| 2020 Q4 | 4.22 Million USD | 27.39% |
| 2019 Q1 | 5.58 Million USD | 9.61% |
| 2019 Q4 | 5.12 Million USD | -17.31% |
| 2019 Q3 | 6.19 Million USD | 5.25% |
| 2019 Q2 | 5.88 Million USD | 5.3% |
| 2019 FY | 5.12 Million USD | 0.45% |
| 2018 FY | 5.09 Million USD | 9.83% |
| 2018 Q3 | 5.14 Million USD | 0.84% |
| 2018 Q1 | 4.78 Million USD | 3.08% |
| 2018 Q2 | 5.1 Million USD | 6.73% |
| 2018 Q4 | 5.09 Million USD | -1.01% |
| 2017 Q4 | 4.64 Million USD | 1.53% |
| 2017 FY | 4.64 Million USD | 15.45% |
| 2017 Q2 | 4.52 Million USD | 7.77% |
| 2017 Q3 | 4.57 Million USD | 1.06% |
| 2017 Q1 | 4.19 Million USD | 4.4% |
| 2016 Q4 | 4.02 Million USD | 8.12% |
| 2016 Q2 | 3.53 Million USD | 71.75% |
| 2016 Q3 | 3.71 Million USD | 5.09% |
| 2016 FY | 4.02 Million USD | 161.72% |
| 2016 Q1 | 2.06 Million USD | 34.11% |
| 2015 Q1 | 2.83 Million USD | 13.64% |
| 2015 Q2 | 215 Thousand USD | -92.41% |
| 2015 Q3 | 1.67 Million USD | 679.53% |
| 2015 FY | 1.53 Million USD | -38.36% |
| 2015 Q4 | 1.53 Million USD | -8.35% |
| 2014 Q4 | 2.49 Million USD | -34.25% |
| 2014 FY | 2.49 Million USD | 780.87% |
| 2014 Q2 | 2.7 Million USD | 403.35% |
| 2014 Q1 | 538 Thousand USD | 246.99% |
| 2014 Q3 | 3.79 Million USD | 39.96% |
| 2013 Q2 | -1.71 Million USD | -123.92% |
| 2013 FY | -366 Thousand USD | 32.47% |
| 2013 Q3 | -88 Thousand USD | 94.86% |
| 2013 Q1 | -765 Thousand USD | -41.14% |
| 2013 Q4 | -366 Thousand USD | -315.91% |
| 2012 Q1 | -605 Thousand USD | 65.99% |
| 2012 Q2 | -1.03 Million USD | -70.25% |
| 2012 Q4 | -542 Thousand USD | 75.27% |
| 2012 FY | -542 Thousand USD | 69.53% |
| 2012 Q3 | -2.19 Million USD | -112.82% |
| 2011 FY | -1.77 Million USD | 32.18% |
| 2011 Q4 | -1.77 Million USD | -190.21% |
| 2011 Q3 | -613 Thousand USD | 65.94% |
| 2011 Q2 | -1.8 Million USD | -4.23% |
| 2011 Q1 | -1.72 Million USD | 34.16% |
| 2010 FY | -2.62 Million USD | -130.96% |
| 2010 Q4 | -2.62 Million USD | -20.21% |
| 2010 Q3 | -2.18 Million USD | -882.08% |
| 2010 Q1 | 496 Thousand USD | -94.14% |
| 2010 Q2 | 279 Thousand USD | -43.75% |
| 2009 Q4 | 8.47 Million USD | 11.14% |
| 2009 FY | 8.47 Million USD | 103.09% |
| 2009 Q1 | 5.1 Million USD | 22.27% |
| 2009 Q2 | 5.75 Million USD | 12.75% |
| 2009 Q3 | 7.62 Million USD | 32.56% |
| 2008 Q3 | 4.86 Million USD | 25.21% |
| 2008 Q4 | 4.17 Million USD | -14.21% |
| 2008 FY | 4.17 Million USD | 54.31% |
| 2008 Q2 | 3.88 Million USD | 19.59% |
| 2008 Q1 | 3.24 Million USD | 20.13% |
| 2007 Q3 | 2.22 Million USD | 1068.7% |
| 2007 Q4 | 2.7 Million USD | 21.32% |
| 2007 Q1 | 288 Thousand USD | -91.92% |
| 2007 Q2 | -230 Thousand USD | -179.86% |
| 2007 FY | 2.7 Million USD | -24.16% |
| 2006 Q3 | 3.48 Million USD | 30.37% |
| 2006 FY | 3.56 Million USD | 5141.18% |
| 2006 Q1 | 1.39 Million USD | 1947.06% |
| 2006 Q2 | 2.67 Million USD | 92.1% |
| 2006 Q4 | 3.56 Million USD | 2.24% |
| 2005 FY | 68 Thousand USD | -48.87% |
| 2005 Q4 | 68 Thousand USD | -33.33% |
| 2005 Q3 | 102 Thousand USD | 203.03% |
| 2005 Q2 | -99 Thousand USD | -127.89% |
| 2005 Q1 | 355 Thousand USD | 166.92% |
| 2004 Q2 | -2.87 Million USD | 51.64% |
| 2004 Q3 | -1.34 Million USD | 53.32% |
| 2004 Q4 | 133 Thousand USD | 109.9% |
| 2004 Q1 | -5.94 Million USD | -1047.29% |
| 2004 FY | 133 Thousand USD | -78.82% |
| 2003 Q3 | 549 Thousand USD | 649.0% |
| 2003 Q1 | -2.76 Million USD | -494.84% |
| 2003 FY | 628 Thousand USD | 235.05% |
| 2003 Q4 | 628 Thousand USD | 14.39% |
| 2003 Q2 | -100 Thousand USD | 96.38% |
| 2002 Q2 | -3.26 Million USD | 43.34% |
| 2002 Q3 | -2.29 Million USD | 29.95% |
| 2002 Q1 | -5.76 Million USD | 39.0% |
| 2002 Q4 | -465 Thousand USD | 79.69% |
| 2002 FY | -465 Thousand USD | 95.08% |
| 2001 Q2 | -12.17 Million USD | -664.51% |
| 2001 FY | -9.45 Million USD | -162.07% |
| 2001 Q4 | -9.45 Million USD | 0.64% |
| 2001 Q3 | -9.51 Million USD | 21.79% |
| 2001 Q1 | -1.59 Million USD | 55.89% |
| 2000 Q1 | -8.04 Million USD | -282.95% |
| 2000 FY | -3.6 Million USD | -71.86% |
| 2000 Q4 | -3.6 Million USD | -8.7% |
| 2000 Q3 | -3.32 Million USD | 44.22% |
| 2000 Q2 | -5.95 Million USD | 25.99% |
| 1999 Q4 | -2.1 Million USD | -110.0% |
| 1999 Q3 | -1 Million USD | 16.67% |
| 1999 Q2 | -1.2 Million USD | 69.23% |
| 1999 Q1 | -3.9 Million USD | 22.0% |
| 1999 FY | -2.1 Million USD | 58.0% |
| 1998 FY | -5 Million USD | 58.68% |
| 1998 Q1 | -10.7 Million USD | 11.57% |
| 1998 Q2 | -8.5 Million USD | 20.56% |
| 1998 Q3 | -6.5 Million USD | 23.53% |
| 1998 Q4 | -5 Million USD | 23.08% |
| 1997 FY | -12.1 Million USD | -175.0% |
| 1997 Q2 | -1.5 Million USD | 46.43% |
| 1997 Q4 | -12.1 Million USD | 15.97% |
| 1997 Q3 | -14.4 Million USD | -860.0% |
| 1997 Q1 | -2.8 Million USD | 37.36% |
| 1996 FY | -4.4 Million USD | -1289.19% |
| 1996 Q4 | -4.47 Million USD | 0.0% |
| 1995 FY | 370 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 90.106% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -577.26% |
| Polarean Imaging plc | -5.94 Million USD | 124.67% |
| Avitar, Inc. | 5.17 Million USD | 71.631% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -606 Thousand USD | 342.079% |
| AVITA Medical, Inc. | -26.23 Million USD | 105.592% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 21057.129% |
| Össur hf. | 395.08 Million USD | 99.629% |
| Zecotek Photonics Inc. | 2.76 Million USD | 46.895% |
| QHSLab, Inc. | 1.72 Million USD | 15.201% |
| Wellstar International, Inc. | 51.36 Million USD | 97.144% |
| Össur hf. | 395.08 Million USD | 99.629% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 131.773% |
| Escalon Medical Corp. | 315.68 Thousand USD | -364.702% |
| Aurora Spine Corporation | 1.9 Million USD | 23.099% |
| BrainsWay Ltd. | -10.32 Million USD | 114.215% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 39.255% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 91.907% |
| Vivos Inc. | -1.59 Million USD | 192.132% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.782% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -201.026% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 371.171% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -129.148% |
| Nanomix Corporation | 11.38 Million USD | 87.119% |
| Theraclion SA | -5.86 Million EUR | 125.015% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 63.191% |
| Positron Corporation | 1.68 Million USD | 13.035% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 8.93% |
| Lombard Medical, Inc. | 11.49 Million USD | 87.238% |
| ALR Technologies Inc. | 19.14 Million USD | 92.339% |
| Stratec SE | 119.12 Million USD | 98.769% |
| Vycor Medical, Inc. | 1.05 Million USD | -39.322% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -2567.513% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -1474.135% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 110.64% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 95.134% |
| VMS Rehab Systems, Inc. | 133.52 USD | -1098611.055% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -132.518% |
| Odyssey Group International, Inc. | 2.1 Million USD | 30.401% |
| United American Healthcare Corporation | -9.32 Million USD | 115.729% |
| ECGI Holdings, Inc. | 3.17 Million USD | 53.741% |
| Capital Group Holdings, Inc. | -3508.00 USD | 41918.672% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -458.606% |
| Urologix, Inc. | 4.61 Million USD | 68.212% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 65.15% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 55.962% |
| SS Innovations International, Inc. | 1.18 Million USD | -23.761% |
| Qualis Innovations, Inc. | 6671.00 USD | -21890.691% |
| Smith & Nephew plc | 2.77 Billion USD | 99.947% |
| NIOX Group Plc | -23.93 Million USD | 106.13% |
| Fuse Medical, Inc. | 1.75 Million USD | 16.434% |
| Broncus Holding Corporation | -81.42 Million USD | 101.802% |
| Brain Scientific Inc. | 2.11 Million USD | 30.664% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 93.531% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -3608.57% |